Jane Street’s Cardlytics CDLX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$17.1K Buy
+1,630
New +$15.9K ﹤0.01% 11220
2025
Q4
Sell
-6,390
Closed -$155K 11223
2025
Q3
$155K Buy
+6,390
New +$106K ﹤0.01% 9860
2024
Q3
Sell
-1,810
Closed -$149K 9625
2024
Q2
$149K Sell
1,810
-860
-32% -$93K ﹤0.01% 8577
2024
Q1
$387K Buy
+2,670
New +$225K ﹤0.01% 7136
2023
Q4
Sell
-3,310
Closed -$546K 9228
2023
Q3
$546K Buy
+3,310
New +$430K ﹤0.01% 6160
2023
Q1
Sell
-1,000
Closed -$57.8K 9096
2022
Q4
$57.8K Buy
+1,000
New +$61.8K ﹤0.01% 8314
2022
Q2
Sell
-2,360
Closed -$1.3M 9730
2022
Q1
$1.3M Sell
2,360
-680
-22% -$411K ﹤0.01% 5578
2021
Q4
$2.01M Sell
3,040
-110
-3% -$84.1K ﹤0.01% 4483
2021
Q3
$2.64M Buy
3,150
+2,060
+189% +$2.09M ﹤0.01% 3909
2021
Q2
$1.38M Buy
1,090
+810
+289% +$914K ﹤0.01% 5110
2021
Q1
$307K Sell
280
-410
-59% -$541K ﹤0.01% 7670
2020
Q4
$985K Buy
690
+210
+44% +$224K ﹤0.01% 4676
2020
Q3
$339K Sell
480
-380
-44% -$276K ﹤0.01% 5705
2020
Q2
$602K Buy
860
+20
+2% +$11.6K ﹤0.01% 4786
2020
Q1
$294K Buy
+840
New +$595K ﹤0.01% 4225

Other funds holding CDLX

Jane Street's CDLX Position: Q1 2026 in Review

Jane Street sold out of Cardlytics (CDLX) in Q1 2026, closing a stake of 65,878 shares — an estimated $643K sold.

Jane Street first reported a position in CDLX in Q3 2019 and held it in 24 quarters. The position peaked at $5.61M in Q1 2024. 58 funds tracked by Wall St. Rank hold CDLX as of Q1 2026.

  • Jane Street reported no remaining Cardlytics position as of Q1 2026 after selling out during the quarter.
  • Jane Street sold 65,878 Cardlytics shares in Q1 2026, an estimated $643K.
  • Jane Street first reported a position in Cardlytics in Q3 2019 and held it in 24 quarters.
  • Jane Street's Cardlytics position peaked at $5.61M in Q1 2024.
  • 58 funds tracked by Wall St. Rank held Cardlytics as of Q1 2026.

Based on Jane Street's 13F filing for Q1 2026, filed 12 May 2026.